Does hydroxychloroquine reduce mortality for COVID-19?

Eur J Intern Med · 2020 · PMC7566795 · PMID 33127218

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

A meta-analysis of completed and ongoing RCTs, pooling findings from published (mostly preprints) or unpublished data, found a borderline significant excess risk of 8% for all-cause mortality for COVID-19 patients treated with HCQ (pooled OR: 1.08; 95% CI: 0.99-1.18) [7] .

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.